PTMScan® Pilot Ubiquitin Remnant Motif (K-ε-GG) Kit #14482
Additional Information
This product is intended for peptide enrichment and mass spectrometry analysis. To learn more about our Proteomics Kits and Services please answer a few questions for our Proteomics group.
Product Information
Product Usage Information
Cells are lysed in a urea-containing buffer, cellular proteins are digested by proteases, and the resulting peptides are purified by reversed-phase solid-phase extraction. Peptides are then subjected to immunoaffinity purification using a PTMScan® Motif Antibody conjugated to protein A agarose beads. Unbound peptides are removed through washing, and the captured PTM-containing peptides are eluted with dilute acid. Reversed-phase purification is performed on microtips to desalt and separate peptides from antibody prior to concentrating the enriched peptides for LC-MS/MS analysis. CST recommends the use of PTMScan® IAP Buffer #9993 included in the kit.
Storage
Protocol
Product Description
Background
- Rush, J. et al. (2005) Nat Biotechnol 23, 94-101.
- Ciechanover, A. (1998) EMBO J 17, 7151-60.
- Hochstrasser, M. (2000) Nat Cell Biol 2, E153-7.
- Hochstrasser, M. (2000) Science 289, 563-4.
- Bernardi, R. et al. (2000) Oncogene 19, 2447-54.
- Aberle, H. et al. (1997) EMBO J 16, 3797-804.
- Salomoni, P. and Pandolfi, P.P. (2002) Nat Cell Biol 4, E152-3.
- Jesenberger, V. and Jentsch, S. (2002) Nat Rev Mol Cell Biol 3, 112-21.
Product Citations: 41
- McCann, J.J. et al. (2020) Cancer Res 80, 430-443.
- Yasuda, S. et al. (2020) Nature 578, 296-300.
- Tufegdzic Vidakovic, A. et al. (2019) Methods 159-160, 146-156.
- Zeng, F. et al. (2019) PLoS Biol 17, e3000525.
- Chen, X.L. et al. (2018) Front Plant Sci 9, 1064.
- Bakos, G. et al. (2018) Nat Commun 9, 4776.
- Christensen, D.G. et al. (2018) MBio 9.
- Wade, B.E. et al. Pulm Circ 8, 2045894018788267.
- Brockmann, M. et al. (2017) Nature 546, 307-311.
- Dogan, T. et al. (2017) J Biol Chem 292, 14311-14324.
- Lumpkin, R.J. et al. (2017) Nat Commun 8, 1171.
- Yi, J.J. et al. (2017) J Biol Chem 292, 12503-12515.
- Potu, H. et al. (2017) Nat Commun 8, 14449.
- Nguyen, D.T.T. et al. (2017) Cell Death Differ 24, 1063-1078.
- de Almagro, M.C. et al. (2017) Cell Death Differ 24, 26-37.
- Huebner, A.R. et al. (2016) Mol Cell Proteomics 15, 1556-71.
- Ivanova, E. and Carpino, N. (2016) Mol Immunol 73, 19-28.
- Li, X.M. et al. (2015) Nat Genet 47, 827-33.
- Onizawa, M. et al. (2015) Nat Immunol 16, 618-27.
- Sohn, S.Y. et al. (2015) J Virol 89, 1744-55.
- Varfolomeev, E. et al. (2015) Biochem J 466, 45-54.
- Yoshida, Y. et al. (2015) Proc Natl Acad Sci U S A 112, 4630-5.
- Yu, K. et al. (2015) J Mol Biol 427, 2121-34.
- Ryder, D.J. et al. (2015) PLoS One 10, e0136247.
- Gispert, S. et al. (2015) Hum Mol Genet 24, 1061-76.
- Krönke, J. et al. (2014) Science 343, 301-5.
- Theurillat, J.P. et al. (2014) Science 346, 85-89.
- Thompson, J.W. et al. (2014) J Biol Chem 289, 28942-55.
- Iesmantavicius, V. et al. (2014) Mol Cell Proteomics 13, 1979-92.
- Tong, Z. et al. (2014) Mol Cell Proteomics 13, 2871-82.
- Tammsalu, T. et al. (2014) Sci Signal 7, rs2.
- Anania, V.G. et al. (2014) Mol Cell Proteomics 13, 145-56.
- Udeshi, N.D. et al. (2013) Nat Protoc 8, 1950-60.
- Carrano, A.C. and Bennett, E.J. (2013) Mol Cell Proteomics 12, 3521-31.
- Buckley, S.M. et al. (2012) Cell Stem Cell 11, 783-98.
- Mathew, R. et al. (2012) Nature 491, 618-21.
- Udeshi, N.D. et al. (2012) Mol Cell Proteomics 11, 148-59.
- Bustos, D. et al. (2012) Mol Cell Proteomics 11, 1529-40.
- Emanuele, M.J. et al. (2011) Cell 147, 459-74.
- Lee, K.A. et al. (2011) J Biol Chem 286, 41530-8.
- Kim, W. et al. (2011) Mol Cell 44, 325-40.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.